🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07605221
Recruiting Not applicable

Nomogram for Astigmatism Correction of KLEx

NCT07605221 · tracked via the Priya Life Science China tracker
Sponsor
Tianjin Eye Hospital
Phase
Not applicable
Started
2025-02-18
Last updated
2026-05-22

Condition(s) studied

Astigmatism

Investigational drug(s) / intervention(s)

nomogram

nomogram: nomogram was added to nomogram group

Study summary

The goal of this clinical trial is to learn if nomogram could promote treatment outcomes in astigmatism correction. The main question it aims to answer is:

does the nomogram could promote treatment outcomes in astigmatism correction? If there is a comparison group: Researchers will compare non-nomogram adopted to see if the outcome acceptable.

Participants will ask to complete 3-month follow-up of manifest refraction and visual acuity test.

Eligibility

Sex
ALL
Min age
18 Years
Max age
45 Years
Healthy volunteers
No
Inclusion Criteria: * age ≥18 years; preoperative sphere -0.50 D to -10.00 D; preoperative cylinder -1.50 D to -5.00 D; stable refraction (±0.50 D) for 1 year; normal corneal topography; central corneal thickness \>500 μm or predicted residual stromal bed \>280 μm; intraocular pressure \<21 mmHg Exclusion Criteria: * ocular or systematic disease

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tianjin Eye Hospital Tianjin Tianjin Municipality Recruiting

More Tianjin Eye Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07605221 on ClinicalTrials.gov ↗ ← All trials in China